Finzati - Logo
XGN logo

Exagen Inc.

XGNMedical - Diagnostics & Research
$0.00
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$160.66M
Growth
-15.2%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.31Healthy liquidity · 3.45Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:18 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$160.66M
52W Range2.59 - 12.23
Beta2.02
Gross Margin58.28%
Oper. Margin-21.13%
Profit Margin-29.97%
Debt/Eq0.31
Current Ratio3.45
Quick Ratio3.45
Revenue 5Y-15.15%

Investment DNA

How strong this company looks for long-term investors

38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
25/100
Price Attractiveness
Cheap or expensive today
64/100
Why this score
Manageable debt level · 0.31Healthy liquidity · 3.45Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$8.00
Mean
$8.50
Median
$8.00
High
$10.00

Company Overview

IPO: 9/19/2019
Industry: Medical - Diagnostics & Research
P/B i: 7.51
Debt / Equity i: 0.31
Operating Margin: -21.13%
Net Margin: -29.97%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.31
Current Ratio: 3.45
Quick Ratio: 3.45
Status: Good

Insider Transactions

Recent executive and insider activity

Stokes Frank
Transaction: 06/09/2026
BUY
Change
+37,500
Price
$4.31
Filing
06/22/2026
Type
BUY
McKhann Chas
Transaction: 06/09/2026
BUY
Change
+37,500
Price
$4.31
Filing
06/22/2026
Type
BUY
KAHN SCOTT D
Transaction: 06/09/2026
BUY
Change
+37,500
Price
$4.31
Filing
06/22/2026
Type
BUY